Skip to main navigation Skip to search Skip to main content

The role of topical metronidazole in the management of infected wounds

Research output: Contribution to journalReview articlepeer-review

Abstract

With an increasing ageing population, the presentation of chronic wounds has risen and as such there is a potential for an increase in infection rates. Infection can delay wound healing, cause malodour, excess exudate and pain, leading to further morbidity, reducing patient quality of life and increasing the cost of treatment. Topical antimicrobials can be used as part of a wound management plan to tackle infection, enabling chronic wounds to progress to healing, particularly if the wound has a decreased or depleted blood supply. Antibiotic
and antiseptic agents have varying antimicrobial activities and can be used in addition to debridement to treat infection. This article focuses on the role of topical metronidazole in treating infected, malodourous wounds and highlights the continued relevance of topical metronidazole in the management of infected wounds.
Original languageEnglish
Pages (from-to)105-109
Number of pages5
JournalWounds UK
Volume14
Issue number5
Publication statusPublished - 1 Nov 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The role of topical metronidazole in the management of infected wounds'. Together they form a unique fingerprint.

Cite this